|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Manganese cyclopentadienyl tricarbonyl (as Mn) | CAS 12079-65-1 | ||
| C5H5Mn(CO)3 | RTECS OO9720000 | ||
|
Synonyms & Trade Names Cyclopentadienylmanganese tricarbonyl, Cyclopentadienyl tricarbonyl manganese, MCT |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.1 mg/m3 [skin] | ||
| OSHA PEL�: C 5 mg/m3 | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Yellow, crystalline solid with a characteristic odor. [Note: An antiknock additive for gasoline. May be found in an oil & gaseous solution.] |
|||
|
MW: 204.1 |
BP: Sublimes |
MLT: 167°F (Sublimes) |
Sol: Slight |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Oxygen |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms In animals: irritation skin; pulmonary edema; convulsions; central nervous system, respiratory system, kidney changes; decreased resistance to infection | |
|
Target Organs
Skin, respiratory system, central nervous system, kidneys |
|
| See also: INTRODUCTION |